Biogen
BIIB
#822
Rank
ยฃ19.04 B
Marketcap
ยฃ130.69
Share price
-1.48%
Change (1 day)
-27.90%
Change (1 year)

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

Biogen (BIIB) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : ยฃ9.42 Billion

According to Biogen's latest financial reports the company's total liabilities are ยฃ9.42 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Biogen - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31ยฃ9.45 B2.44%
2022-12-31ยฃ9.22 B-3.56%
2021-12-31ยฃ9.56 B-6.38%
2020-12-31ยฃ10.22 B-3.54%
2019-12-31ยฃ10.59 B9.74%
2018-12-31ยฃ9.65 B18.06%
2017-12-31ยฃ8.17 B-6.1%
2016-12-31ยฃ8.71 B27.43%
2015-12-31ยฃ6.83 B204.01%
2014-12-31ยฃ2.24 B14.38%
2013-12-31ยฃ1.96 B0.34%
2012-12-31ยฃ1.95 B16.1%
2011-12-31ยฃ1.68 B-1.45%
2010-12-31ยฃ1.71 B20.99%
2009-12-31ยฃ1.41 B-21.59%
2008-12-31ยฃ1.80 B15.86%
2007-12-31ยฃ1.55 B117.47%
2006-12-31ยฃ0.71 B-16.31%
2005-12-31ยฃ0.85 B-29.77%
2004-12-31ยฃ1.21 B-11.05%
2003-12-31ยฃ1.36 B131.22%
2002-12-31ยฃ0.59 B130.8%
2001-12-31ยฃ0.25 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ยฃ65.70 B 597.29%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ27.89 B 195.98%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ108.26 B 1,048.97%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ100.04 B 961.69%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ85.23 B 804.52%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.21 B-97.76%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ47.96 B 408.97%๐Ÿ‡ซ๐Ÿ‡ท France
ยฃ2.45 B-73.94%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ3.06 B-67.47%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.71 B-81.77%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands